Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Clin Genitourin Cancer. 2015 Mar 5;13(5):410–420. doi: 10.1016/j.clgc.2015.02.009

Figure 2.

Figure 2

Randomization of patients to treatment arms in ATLANTIS trial. Tumor tissue is prospectively screened for clinically relevant biomarkers to identify patients who could potentially benefit from maintenance therapy following 4 to 8 cycles of first-line chemotherapy.